Deuterium

01/01/2014 - "In vitro, in vivo and clinical studies have demonstrated anti-cancer effects of deuterium depleted water (DDW). "
07/01/2013 - "Recent studies have demonstrated that natural water that has 65% of the deuterium concentration depleted, can exhibit anti-tumor properties. "
10/01/2012 - "Studies have shown that water with a low deuterium concentration (<65% percent of volume) can inhibit cancer growth. "
08/05/2005 - "In the present study, deuterium exchange mass spectrometry was used to define the structural boundaries of the RIZ1 PR domain and to map sites of missense mutations that occur in human cancers and reduce methyltransferase activity. "
10/01/1990 - "The purpose of this study was to validate the bioelectrical impedance (BI) method for body composition estimation in 33 elderly cancer patients (mean age 66 +/- 9 years) using the deuterium dilution technique (2H2O) as the reference method. "

07/01/2005 - "(1) To study the validity of field methods of measuring body fat (multiple skinfolds and bioimpedance) against a criterion method (deuterium dilution) and (2) To compare the prevalence of obesity (WHO 2000 criteria for BMI) with adiposity (body fat >25%) in middle-aged Indian men in rural and urban Pune. "
02/01/1997 - "However, the mean of their body fat, as estimated by the standard deuterium dilution method, was about 30% which is suggestive of an unapparent obesity prevailing in this class of people in Bangladesh."
12/01/1950 - "The turnover of body fat in obesity resulting from hypothalamic injury studied with the aid of deuterium."
01/01/2015 - "to assess the effect of overweight and obesity on the equilibrium time of the stable isotope deuterium in saliva samples of older adults. "
01/01/2009 - "Determinations of glucose turnover based on infusion of deuterium-labelled glucose are frequently undertaken in studies involving the pathophysiology of diabetes or obesity or the metabolic response to physical exercise. "

11/01/2012 - "This study demonstrates that LC-HR-MS is a suitable platform for toxicology screening for a pain management population and that quantitative accuracy and sensitivity are comparable to that achieved with LC-MS-MS. The specificity of LC-HR-MS is improved by the addition of deuterium labeled internal standards and the implementation of relative retention time matching."

01/16/2015 - "The observed insensitivity of ion temperature to a varying deuterium fraction is shown to be a signature of ion thermal decoupling in shock-heated plasmas. "
06/06/2014 - "The low opacity of the remaining shell at bang time allows for a measurement of the x-ray emission of the reflected central shock in a deuterium plasma. "
01/01/2012 - "Plasmas 5, 4357 (1998)], shock compression of a deuterium-filled foam is less than that predicted for a uniform medium of the same average density. "
05/13/2011 - "These experiments produced the highest shock velocity observed in liquid deuterium (U(s) = 135  km/s at ∼2500  GPa) and also the first observation of convergence effects on the shock velocity. "
05/13/2011 - "This Letter reports measurements of multiple spherical shock waves in liquid deuterium that facilitate timing inertial confinement fusion shocks to the required precision. "

08/01/2008 - "These results demonstrate that the introduction of deuterium at different positions in the L-DOPA molecule dramatically changes its behavioral and neurochemical profile and suggest that L-DOPA treatment of Parkinson's disease may be improved in this way."
01/01/1999 - "We investigated urine and serum samples from three patient groups: (1) 33 in-patients in acute alcohol withdrawal; (2) 30 detoxified in-patients (treated for at least 4 weeks) from a 'motivation station'; and (3) 43 neuro-rehabilitation patients (non-alcoholics; most of them suffering from stroke, traumatic brain injury, Parkinson's disease etc.) using gas chromatography/mass spectrometry (GC/MS) with deuterium-labelled EtG as the internal standard and additionally in the second group of patients using liquid chromatography (LC/MS-MS). "
02/01/2015 - "Deuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor."